Tegafur is a fluoropyrimidine-based chemotherapy prodrug primarily indicated for the treatment of colorectal cancer, where it functions as a precursor to active cytotoxic agents. Within this category,… Read more








Tegafur is a fluoropyrimidine-based chemotherapy prodrug primarily indicated for the treatment of colorectal cancer, where it functions as a precursor to active cytotoxic agents. Within this category, researchers can access a comprehensive range of high-quality reference standards essential for pharmaceutical development and quality control. This collection includes the active pharmaceutical ingredient, critical degradation products, and specific impurities such as 5-ethoxy and 5-methoxy derivatives. Additionally, stable isotope labelled compounds, such as deuterium and carbon-13/nitrogen-15 labelled versions, are available to serve as internal standards for precise quantification during pharmacokinetic investigations and impurity profiling. These analytical tools allow laboratories to support method validation, assess drug substance purity, and accurately monitor the metabolic conversion of the parent compound into metabolites like tetrahydrofuryluracil, ensuring compliance with regulatory standards throughout the drug development lifecycle.